BackCodiak Biosciences Overview

Codiak Biosciences Other Current Assets

Track Codiak Biosciences's other current assets ($9.5M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$9.47M
77.73% YoYΔ $4.14M vs prior year quarter

Peer average

Loading

Codiak Biosciences Other Current Assets History

Loading

Codiak Biosciences vs. peers: Other Current Assets Comparison

Loading

Codiak Biosciences Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Codiak Biosciences (CDAK) FAQ

As of the most recent data (September 2022), CDAK shows a other current assets of $9.5M. That compares with $5.3M in the prior-year period — up 77.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CDAK's other current assets is now $9.5M (was $5.3M) — a 77.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Codiak Biosciences is outperforming or lagging.

Tracking CDAK's other current assets over time shows whether Codiak Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $9.5M That compares with $5.3M in the prior-year period — up 77.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Codiak Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $9.5M) with ownership activity and broader fundamentals.

Codiak Biosciences's other current assets is $9.5M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.